Hybrid natural hydrogels integrated with voriconazole-loaded microspheres for ocular antifungal applications
- 30 March 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (15) , 3377-3388
Abstract
Fungal keratitis is a major threat to ocular morbidity and blindness. The therapeutic efficacy of eye drops against fungal keratitis is limited by their poor bioavailability, especially in patients with corneal stromal ulcers that lead to tissue defects. Therefore, intervention measures that can control fungal infection while promoting tissue regeneration are desirable. Herein, we designed and fabricated natural antifungal hydrogels that comprise a decellularized porcine cornea (DPC), gelatin and microspheres (MCs) containing voriconazole (Vor) for the management of fungal keratitis with focal corneal stromal defects. The size and structure of the Vor-loaded MCs were characterized by scanning electron microscopy (SEM), Fourier-transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC). The antifungal drug Vor showed that continuous release from the hybrid hydrogel system for up to 7 days and that MCs loading did not affect the mechanical properties, in vitro release profile or cytocompatibility of the hybrid hydrogel. Moreover, the Vor-loaded hydrogels exhibited excellent antifungal properties against F. solani and A. fumigatus. The efficiency of the natural antifungal hydrogel was evaluated by an ex vivo infectious rabbit corneal defect model. After 24 h, the number of fungal colony-forming units (CFU) significantly decreased in antifungal hydrogel-treated corneal tissue compared with that in non-treated corneas and corneas treated with hydrogels without Vor. The above results demonstrated that this natural hydrogel-based drug delivery system holds great promise for preventing fungal keratitis infection while promoting focal corneal stromal regeneration. Additionally, natural hybrid hydrogels might be a candidate material for use with various drugs in the effective treatment of many other ocular diseases.Keywords
This publication has 37 references indexed in Scilit:
- Short imidazolium chains effectively clear fungal biofilm in keratitis treatmentBiomaterials, 2013
- Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo studyNanomedicine: Nanotechnology, Biology and Medicine, 2013
- Determination of Voriconazole in Human Plasma by HPLC–ESI-MS and Application to Pharmacokinetic StudyJournal of Chromatographic Science, 2012
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012
- Risk Factors, Clinical Features, and Outcomes of Recurrent Fungal Keratitis after Corneal TransplantationOphthalmology, 2010
- Voriconazole in the treatment of fungal eye infections: a review of current literatureBritish Journal of Ophthalmology, 2008
- Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacyInternational Journal of Pharmaceutics, 2008
- Challenges and obstacles of ocular pharmacokinetics and drug deliveryAdvanced Drug Delivery Reviews, 2006
- Spectrum of Fungal Keratitis in North ChinaOphthalmology, 2006
- Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004)Journal of Clinical Microbiology, 2005